Your browser doesn't support javascript.
loading
Anti-Double-Stranded DNA Antibodies Recognize DNA Presented on HLA Class II Molecules of Systemic Lupus Erythematosus Risk Alleles.
Tsuji, Hideaki; Ohmura, Koichiro; Jin, Hui; Naito, Ryota; Arase, Noriko; Kohyama, Masako; Suenaga, Tadahiro; Sakakibara, Shuhei; Kochi, Yuta; Okada, Yukinori; Yamamoto, Kazuhiko; Kikutani, Hitoshi; Morinobu, Akio; Mimori, Tsuneyo; Arase, Hisashi.
Afiliación
  • Tsuji H; Kyoto University, Kyoto, Japan; World Premier International Immunology Frontier Research Center, Osaka University, Suita, Japan, and Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
  • Ohmura K; Kyoto University, Kyoto, Japan (current address: Kobe City Medical Center General Hospital, Kobe, Japan), : Kyoto University, Kyoto, Japan.
  • Jin H; Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
  • Naito R; Kyoto University, Kyoto, Japan; World Premier International Immunology Frontier Research Center, Osaka University, Suita, Japan, and Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
  • Arase N; Osaka University Graduate School of Medicine, Suita, Japan.
  • Kohyama M; World Premier International Immunology Frontier Research Center, Osaka University, Suita, Japan, and Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
  • Suenaga T; World Premier International Immunology Frontier Research Center, Osaka University, Suita, Japan, and Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
  • Sakakibara S; World Premier International Immunology Frontier Research Center, Osaka University, Suita, Japan.
  • Kochi Y; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan, and Tokyo Medical and Dental University, Tokyo, Japan.
  • Okada Y; World Premier International Immunology Frontier Research Center, Osaka University, Suita, Japan; Osaka University Graduate School of Medicine, Suita, Japan and RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Yamamoto K; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Kikutani H; World Premier International Immunology Frontier Research Center, Osaka University, Suita, Japan.
  • Morinobu A; Kyoto University, Kyoto, Japan (current address: Kobe City Medical Center General Hospital, Kobe, Japan), : Kyoto University, Kyoto, Japan.
  • Mimori T; Kyoto University, Kyoto, Japan (current address: Kobe City Medical Center General Hospital, Kobe, Japan), : Kyoto University, Kyoto, Japan.
  • Arase H; World Premier International Immunology Frontier Research Center, Osaka University, Suita, Japan; Research Institute for Microbial Diseases, Osaka University, Suita, Japan, and Center for Infectious Disease Education and Research, Osaka University, Suita, Japan.
Arthritis Rheumatol ; 74(1): 105-111, 2022 01.
Article en En | MEDLINE | ID: mdl-34164946
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ADN / Antígenos de Histocompatibilidad Clase II / Anticuerpos Antinucleares / Lupus Eritematoso Sistémico Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Arthritis Rheumatol Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ADN / Antígenos de Histocompatibilidad Clase II / Anticuerpos Antinucleares / Lupus Eritematoso Sistémico Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Arthritis Rheumatol Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos